During Trumps 2017-2021 tenure, Indian pharma equities faced challenges, including increased FDA regulatory actions that ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

In the corresponding quarter of the previous fiscal, Piramal Pharma posted a net profit of ₹10.1 crore, the company said in a ...

For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to ...

Strides Pharma share price has fallen over 10% in one month and 16% in three months. However, Strides Pharma stock has ...

Bajaj Healthcare shares hit a record high of Rs 655 and rallied 17% on the BSE in Friday's intraday trade after it received ...

Here is how Amneal Pharmaceuticals (AMRX) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc.

Here is how Alnylam Pharmaceuticals (ALNY) and Medpace (MEDP) have performed compared to their sector so far this year.